Fingerprint
Dive into the research topics of 'A multicenter phase II study of cisplatin, pemetrexed, and bevacizumab in patients with advanced malignant mesothelioma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
A multicenter phase II study of cisplatin, pemetrexed, and bevacizumab in patients with advanced malignant mesothelioma
Jonathan E. Dowell, Frank R. Dunphy, Robert N. Taub, David E. Gerber, Likheng Ngov, Jingsheng Yan, Yang Xie, Hedy Lee Kindler
Research output: Contribution to journal › Article › peer-review
79
Scopus
citations